HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Dishman Carbogen Amcis’ arm clears USFDA inspection at Switzerland site with zero observations
Sep-15-2026

Dishman Carbogen Amcis’ wholly owned subsidiary -- Carbogen Amcis AG has successfully completed its first United States Food and Drug Administration (USFDA) inspection at manufacturing site located at Vionnaz, Switzerland without any Form 483. This successful inspection reflects the strong focus on quality parameters across the company and its subsidiaries. 

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


  RELATED NEWS >>